Sigma Planning Corp’s IN8bio INAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,356
Closed -$116K 1290
2025
Q1
$116K Sell
23,356
-11,357
-33% -$90.6K ﹤0.01% 1153
2024
Q4
$268K Buy
34,713
+6,337
+22% +$55.7K 0.01% 975
2024
Q3
$230K Buy
28,376
+8,387
+42% +$152K 0.01% 1076
2024
Q2
$508K Buy
19,989
+2,820
+16% +$90.5K 0.02% 717
2024
Q1
$608K Buy
17,169
+12,761
+289% +$481K 0.02% 681
2023
Q4
$182K Sell
4,408
-5,094
-54% -$163K 0.01% 789
2023
Q3
$296K Buy
9,502
+189
+2% +$7.09K 0.01% 925
2023
Q2
$430K Buy
9,313
+2,516
+37% +$157K 0.02% 791
2023
Q1
$265K Buy
6,797
+3,492
+106% +$195K 0.01% 1045
2022
Q4
$229K Buy
3,305
+13
+0.4% +$728 0.01% 1087
2022
Q3
$199K Buy
3,292
+34
+1% +$2.28K 0.01% 1125
2022
Q2
$221K Hold
3,258
0.01% 1125
2022
Q1
$326K Buy
3,258
+2,305
+242% +$258K 0.01% 1018
2021
Q4
$126K Buy
+953
New +$188K ﹤0.01% 1311

Other funds holding INAB

Sigma Planning Corp's INAB Position: Q2 2025 in Review

Sigma Planning Corp sold out of IN8bio (INAB) in Q2 2025, closing a stake of 23,356 shares — an estimated $116K sold.

Sigma Planning Corp first reported a position in INAB in Q4 2021 and held it in 14 quarters. The position peaked at $608K in Q1 2024. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Sigma Planning Corp reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 23,356 IN8bio shares in Q2 2025, an estimated $116K.
  • Sigma Planning Corp first reported a position in IN8bio in Q4 2021 and held it in 14 quarters.
  • Sigma Planning Corp's IN8bio position peaked at $608K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Sigma Planning Corp's 13F filing for Q2 2025, filed 5 Aug 2025.